05-Sep-2022 | Facts and Factors
According to Facts and Factors, the protein expression market size was worth USD 2.30 billion in 2021 and is estimated to grow to USD 4.71 billion by 2028, with a compound annual growth rate (CAGR) of approximately 12.70% over the forecast period. The report analyzes the protein expression market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the protein expression market.
The biotechnological process of protein expression produces a specific protein. Usually, this is done by modifying an organism's gene expression to increase the recombinant gene expression in the organism. The development of genetic engineering and recombinant technology has opened up numerous possibilities for producing and separating heterologous proteins in science, medicine, and industry. Thanks to important developments in biotechnology, large-scale recombinant protein expression and isolation are now feasible. One of the immediate successes is the development of recombinant proteins that can enter a cell. Such developments open up new possibilities in therapeutic medicine by concentrating on intracellular mechanisms or employing therapeutic proteins to replace intracellularly active enzymes.
Browse the full “Protein Expression Market Size, Share, Growth Analysis Report By Expression System (Prokaryotic Expression Systems, Mammalian Cell Systems, Insect Cell Systems, Yeast Systems, Other Systems), By Product (Reagents, Expression Vectors, Competent Cells, Instruments, Services), By Application (Therapeutic, Industrial, Research), By End-Use (Pharmaceutical and biotechnological companies, Academic research, Contract research organizations and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/protein-expression-market
Age-related illnesses, a growing geriatric population, and an increase in the prevalence of chronic diseases like cancer are some of the factors boosting the protein expression market's growth. The protein expression market is also growing due to rising spending on protein research. However, the market's expansion is constrained by the high cost of manufacturing protein products. The market is further constrained by a severe shortage of qualified healthcare workers and a lack of regional knowledge. Inventions like mass spectrometry, molecular genetics, and improvements in manufacturing processes are the main factors driving the market for protein therapy. Additionally, the market should benefit from the quick advancements in medical technology, improved disease identification, and expanding the healthcare sector in emerging regions.
The protein expression market has been segmented into expression systems, products, applications, end-use and regions. Based on expression systems, the market has been segmented into prokaryotic expression systems, mammalian cell systems, insect cell systems, yeast systems, and others. The prokaryotic expression systems segment dominated in 2021. Based on product, the market is segmented as reagents, expression vectors, competent cells, instruments, and services. The reagents segment is expected to grow during the forecast period in 2021. Based on application, the market is segmented as therapeutic, industrial, and research. The major portion of this market in 2021 was devoted to therapeutic uses. Based on end-use, the market is segmented into pharmaceutical and biotechnological companies, academic research, contract research organizations and others. The pharmaceutical and biotechnological segments dominated the market in 2021.
The market for protein expression systems worldwide is divided into five regions based on geography: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In 2021, North America dominated the market. This area is home to numerous sizable biopharmaceuticals, pharmaceutical, and biotechnology firms, including Merck KGaA, Amgen Inc., and F. Hoffmann-La Roche Ltd. The U.S. dominated the market for protein expression in North America. Along with an increase in chronic diseases, including cardiovascular and blood diseases, the country is seeing more research focus on stem cells and cancer. With the support of cutting-edge protein expression products, many biopharmaceutical companies are advancing stem cell research as one of the most promising treatments for these diseases. As a result, it is predicted that demand for protein expression products will increase throughout the projection period.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 2.30 Billion |
Projected Market Size in 2028 |
USD 4.71 Billion |
CAGR Growth Rate |
12.70% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Agilent Technologies Inc., Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc., Merck KGaA, Promega Corporation, New England Biolabs, Qiagen, Takara Bio Inc., Oxford Expression Technologies, Lucigen Corporation, and Others |
Key Segment |
By Expression Systems, Product, Application, End-use, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key players in the protein expression market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc, Bio-Rad Laboratories, Inc., Merck KGaA, Promega Corporation, New England Biolabs, Qiagen, Takara Bio, Inc., Oxford Expression Technologies, Lucigen Corporation.
Recent Development:
- In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company Qiagen (Germany). This acquisition will help Thermo Fisher Scientific boost its precision medicine offering through molecular diagnostics and improved life sciences solutions.
Global Protein Expression Market is segmented as follows:
By Expression Systems
- Prokaryotic expression systems
- Mammalian cell systems
- Insect cell systems
- Yeast systems
- Other systems
By Product
- Reagents
- Competent cells
- Expression vectors
- Services
- Instruments
By Application
- Therapeutic
- Industrial
- Research
By End-use
- Pharmaceutical and biotechnological companies
- Academic research
- Contract research organizations
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
